Optilume DCB combines mechanical dilation with paclitaxel coating for effective urethral patency maintenance in recurrent anterior urethral strictures. ROBUST III trial shows significant improvements ...

The TRAVERSE trial is the largest randomized placebo-controlled study on testosterone therapy, impacting clinical perspectives on its risks and benefits. The study alleviates concerns about ...

MED3000 gel is FDA-cleared for over-the-counter use and improves erectile dysfunction outcomes for men and partners. A 12-week study across multiple countries showed significant improvements in SEP ...

A 400 mg BID dose of oral testosterone undecanoate significantly increases serum testosterone levels and improves symptoms in hypogonadal men. The study observed decreased sex hormone binding globulin ...

"This first paper was really to show that our research methodology was feasible and acceptable with pediatric urology patients and families. We've done that, and now we have a huge corpus of data that ...

Effective Xiaflex administration for Peyronie disease involves back-to-back injections and achieving an erection with the first injection of each series. Optimizing dosage, dilution, and incorporating ...

The NRG-GU011 trial evaluates relugolix plus SBRT versus SBRT alone in men with PSA recurrence and PSMA-PET-detected metastases. The study addresses whether targeted radiation can delay hormone ...

The "drain and retain" technique is safe for IPP revision surgeries without infection, avoiding morbidity from reservoir removal. Study across seven US centers showed similar infection rates for ...

FSD content is scarce in urology (1.4%) and OB/GYN (5.3%) residency programs, compared to MSD content in 50% of urology programs. No urology programs included FSD curricula, while 10 of 12 OB/GYN ...

Bel-sar demonstrated promising efficacy and safety in NMIBC, with complete clinical responses in most low-grade disease patients. The treatment induces tumor cell necrosis and pro-immunogenic cell ...

Active surveillance is effective for low-risk prostate cancer, with low metastasis and mortality rates over 10 years. The study underscores the need for improved risk stratification to minimize ...

According to iota Biosciences, the device is “designed to deliver electrical stimulation directly to the bladder wall, inducing contractions that facilitate bladder emptying in individuals impacted by ...